Yaakov Naparstek, MD

Yaakov Naparstek, MD is a graduate of the Hadassah-Hebrew University Medical School in Jerusalem, Israel and Boards certified in Internal Medicine, Rheumatology and Clinical Immunology and Allergy. He has been a research fellow at the Department of Cell Biology, Weizmann Institute of Science, Rehovot and at the Cancer Research Center, Tuft’s University, Boston and a visiting Professor at the NIAMS, National Institute of Health, Bethesda and at the Department of Neuroimmunology, Stanford University, Stanford. Dr. Naparstek is currently a Professor of Medicine in the Hebrew University, Jerusalem. He was the Chairman of Medicine in the Hadassah University Hospital, as well as the Director of the Hadassah Clinical Immunology and Rheumatology Center. Dr. Naparstek's main research interests are in the fields of autoimmunity, SLE and autoimmune arthritis. In recent years his research group has been focusing on the identification of the target antigens in SLE and in autoimmune arthritis and in the attempts to develop antigen-specific therapeutic modalities to those diseases and is the founder and chief scientist of the Verto Medical and Protab Therapeutics biotechnological companies